Paloma Partners’s ChemoCentryx, Inc. CCXI Stock Holding History

Paloma Partners’s Portfolio CCXI Stock Details CCXI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-12,100	Closed	-$159K	–	2056
2018 Q2	$159K	Buy	+12,100	New	+$145K	﹤0.01%	1499

Other funds holding CCXI

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Paloma Partners's CCXI Position: Q3 2018 in Review

Paloma Partners sold out of ChemoCentryx, Inc. (CCXI) in Q3 2018, closing a stake of 12,100 shares — an estimated $159K sold.

Paloma Partners first reported a position in CCXI in Q2 2018 and held it in 1 quarter. The position peaked at $159K in Q2 2018. 106 funds tracked by Wall St. Rank hold CCXI as of Q3 2018.

Paloma Partners reported no remaining ChemoCentryx, Inc. position as of Q3 2018 after selling out during the quarter.
Paloma Partners sold 12,100 ChemoCentryx, Inc. shares in Q3 2018, an estimated $159K.
Paloma Partners first reported a position in ChemoCentryx, Inc. in Q2 2018 and held it in 1 quarter.
Paloma Partners's ChemoCentryx, Inc. position peaked at $159K in Q2 2018.
106 funds tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q3 2018.

Based on Paloma Partners's 13F filing for Q3 2018, filed 14 Nov 2018.